Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Accounts Payables (2020 - 2025)

SOPHiA GENETICS's Accounts Payables history spans 6 years, with the latest figure at $9.0 million for Q4 2025.

  • On a quarterly basis, Accounts Payables rose 71.65% to $9.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.0 million, a 71.65% increase, with the full-year FY2025 number at $9.0 million, up 71.65% from a year prior.
  • Accounts Payables hit $9.0 million in Q4 2025 for SOPHiA GENETICS, up from $6.1 million in the prior quarter.
  • Over the last five years, Accounts Payables for SOPH hit a ceiling of $9.0 million in Q4 2025 and a floor of $4.6 million in Q1 2025.
  • Historically, Accounts Payables has averaged $6.5 million across 5 years, with a median of $6.2 million in 2024.
  • Biggest five-year swings in Accounts Payables: tumbled 35.93% in 2022 and later surged 71.65% in 2025.
  • Tracing SOPH's Accounts Payables over 5 years: stood at $6.7 million in 2021, then decreased by 8.25% to $6.2 million in 2022, then decreased by 12.78% to $5.4 million in 2023, then dropped by 3.17% to $5.2 million in 2024, then surged by 71.65% to $9.0 million in 2025.
  • Business Quant data shows Accounts Payables for SOPH at $9.0 million in Q4 2025, $6.1 million in Q3 2025, and $7.7 million in Q2 2025.